Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
2 The development of and approval of new antihyperglycemic medications has favored the use of different pharmacological families with remarkable properties for the management of additional comorbidities such as renal disease, cardiovascular disease, and non-alcoholic fatty liver disease, that are highly prevalent in this subset
A., Hanyaloglu, A
)
However: Wegovy is dosed at a higher level (up to 2.4 mg/week), which may lead to faster or greater weight loss
Most recently, there are new indications for chronic kidney disease and sleep apnea
Humana explicitly excludes weight loss as a covered indication for GLP-1 medicationsthis isn't a prior authorization denial, it's a plan exclusion that blocks claims at the pharmacy level
US$ 22.15
US$ 22.05
US$ 25.73
US$ 26.07
US$ 22.25
US$ 23.08
US$ 27.08
